Suspension of trading of securities on AIM
31 Mars 2009 - 8:30AM
UK Regulatory
TIDMYRK
RNS Number : 7656P
York Pharma plc
31 March 2009
31 March 2009
York Pharma Plc
(the "Company")
Suspension of trading of securities on AIM
On 20 March 2009, the Board of the Company announced that it was in discussions
with two potential offerors and that these discussions included the provision of
the necessary short term funding facilities to allow the Company to continue
trading through the period needed to complete any formal offer for the Company
under the Takeover Code.
It was also announced on 20 March 2009 that the publication of the Company's
results for the financial year ended 30 September 2008 (the "Results") would
only take place after the Company had secured its short term funding needs.
Discussions with the parties continue. However, as such short term funding is
not yet available, the Company will now not be able, as required by the AIM
Rules, to publish its Results prior to 31 March 2009. Accordingly, in
accordance with the AIM Rules, all the Ordinary Shares and Warrants have been
temporarily suspended today from trading on AIM, pending the publication of the
Company's Results.
The Board will provide a further update as and when appropriate.
For more information please contact:
+--------------------------------------+--------------------------------------+
| York Pharma Plc | Tel: +44 (0) 1908 764 020 |
| Richard Anderson, Chief Executive | |
| Officer | |
| Ian Miscampbell, Chief Financial | |
| Officer | |
+--------------------------------------+--------------------------------------+
| | |
+--------------------------------------+--------------------------------------+
| Collins Stewart Europe Limited | Tel: +44 (0) 207 523 8350 |
| Hugh Field / Adam Cowen | |
+--------------------------------------+--------------------------------------+
| | |
+--------------------------------------+--------------------------------------+
| Financial Dynamics | Tel: +44 (0) 207 831 3113 |
| Ben Brewerton / Emma Thompson | |
+--------------------------------------+--------------------------------------+
Collins Stewart Europe Limited ("Collins Stewart") which is regulated in the
United Kingdom by The Financial Services Authority is acting for the Company in
relation to the matters described in this announcement and is not advising any
other person, and accordingly will not be responsible to anyone other than the
Company for providing the protections afforded to customers of Collins Stewart
or for providing advice in relation to the matters described in this
announcement.
About York Pharma (YRK.L)
York Pharma is a pharmaceutical group, established in 2003, which develops,
markets and supplies branded dermatological products to pharmaceutical
wholesalers, hospitals and general practitioners within the field of
dermatology.
This information is provided by RNS
The company news service from the London Stock Exchange
END
SRSDGGFFMGMGLZZ
York Pharma (LSE:YRK)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
York Pharma (LSE:YRK)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about York Pharma (London Stock Exchange): 0 recent articles
Plus d'articles sur York Pharma plc